Abstract
In the 2009 guidelines from the BMLA, the use of non-essential aesthetic lasers was contraindicated in patients receiving medication that causes whole-body photosensitisation as well as those causing local light sensitisation. Following this and anecdotal advice, many laser centres refuse to treat patients who are on known photosensitive medication. Therefore, specific patient cohorts that would benefit from laser therapy are being denied because of medications, such as long-term antibiotics for chronic facial acne. This article reviews the published literature on lasers and photosensitive medications, the mechanisms of photosensitivity and the role of laser in its production. The aim is to analyse the available evidence regarding adverse reactions to laser treatment related to photosensitive medication. A PubMed review of published article titles and abstracts was performed using the search term Laser with each of the following terms individually: photosensitive, photosensitiser, photosensitizer, phototoxicity, photoallergy, complications, case-report, tetracycline, minocycline, amiodarone, nitrofurantoin and medication. Four publications were identified, none of which reported any complication in the use of laser in patients taking photosensitising medication. As there are no published accounts of adverse effects of laser in patients with photosensitive medication, we performed a review of the mechanism of photosensitivity by compiling a list of photosensitive medication and the peak wavelength of radiation required to activate the drug. We recommend a national database of drugs and the wavelengths causing photosensitive reactions of each which a laser department can access prior to treatment.
Similar content being viewed by others
References
British Medical Laser Association. Drugs & lasers/IPL (2010) http://www.bmla.co.uk/index.php/file-downloads/cat_view/38-other?start=5. Accessed 1 Jun 2012
Chen WR, Adams RL, Carubelli R, Nordquist RE (1997) Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment. Cancer Lett 115(1):25–30
Silva JCE, Lacava ZGM, Kuckelhaus S et al (2004) Evaluation of the use of low level laser and photosensitizer drugs in healing. Lasers Surg Med 34(5):451–457
Gerasimenko M, Skovorod’ko S, Kondakova O, Varavva A, Barybin V, Mendeleev V (2006) Realization of optic activatory mechanism in laser-medication impact. Vopr Kurortol Fizioter Lech Fiz Kult 2:27–31
Castro DJ, Haghighat S, Saxton RE et al (1992) Biodistribution of rhodamine-123 in nude mice heterotransplanted with human squamous cell carcinomas. Laryngoscope 102(8):868–874
Lehmann P, Schwarz T (2011) Photodermatoses: diagnosis and treatment. Dtsch Arztebl Int 108(9):135–141
Lugović L, Situm M, Ozanić-Bulić S, Sjerobabski-Masnec I (2007) Phototoxic and photoallergic skin reactions. Coll Anthropol 31(Suppl 1):63–67
Braun-Flaco O, Plewig G, Wolff HH, Burgdorf WHC (2000) In: Bischoff W (ed) Dermatology, 2nd edn. Springer, Berlin
Moore DE (1998) Mechanisms of photosensitization by phototoxic drugs. Mutat Res Fundam Mol Mech Mutagen 422(1):165–173
Wu Q, Christensen LA, Legerski RJ, Vasquez KM (2005) Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells. EMBO Rep 6(6):551–557
Gould JW, Mercurio MG, Elmets CA (1995) Cutaneous photosensitivity diseases induced by exogenous agents. J Am Acad Dermatol 33(4):551–573
Allen JE (1993) Drug-induced photosensitivity. Clin Pharm 12(8):580–587
Lim J, Goh C (1994) Lasers used in dermatology. Ann Acad Med Singap 23(1):52–59
Conflict of interest
The authors have no conflict of interest to declare.
Funding
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kerstein, R.L., Lister, T. & Cole, R. Laser therapy and photosensitive medication: a review of the evidence. Lasers Med Sci 29, 1449–1452 (2014). https://doi.org/10.1007/s10103-014-1553-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-014-1553-0